WHO ICTRP trial
Evaluation of The effect of clomiphene or letrozole in the treatment of…
IRCT2015100223621N4 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015100223621N4 |
|---|---|
| Public title | Evaluation of The effect of clomiphene or letrozole in the treatment of infertility |
| Scientific title | Comparison of pregnancy rate with clomiphene citrate and letrosole and clomiphene alone in infertile patients with polycystic ovary syndrome |
| Primary sponsor | Vice Chancellor for research of Iran Univercity of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Female infertility. Female infertility associated with anovulation;Female infertility associated with anovulation |
| Interventions | Intervention 1: 100 mg daily clomiphene(Ovumid; Iran Hormone, Tehran, Iran) , the third day of menstruation to 5 days. Intervention 2: 5 mg letrozole (Letrozole 2.5 ; SOHA Pharmaceutical Co, Tehran, Iran) daily, the third day of… |
| Registration date | Jan 10, 2016 |
| Target size | 450 |
| Secondary IDs | 94-02-30-25979 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: